Chong Kun Dang paid ₩2.5 billion ($2.2 million) to SkyLabs for the right to sell the CART-I cardio tracker to consumers in South Korea, The Korea Herald reported today.
Worn on a finger, the CART-I continuously monitors cardiac signals without any user intervention, according to SkyLabs. The device provides photoplethysmography (PPG) signals to measure heart rate (HR) and to identify atrial fibrillation or its burden,. The device also tracks electrocardiogram(ECG) signals to offer supplementary information to doctors.
South Korea’s Ministry of Food and Drug Safety has certified the CART-I, which also has a CE Mark in the EU.